Overview
Glomerulosclerosis refers to scarring of the glomeruli, often leading to impaired kidney function. It involves podocyte loss and can arise from various mechanisms including hemodynamic stress and potential paraneoplastic effects 12.Diagnosis
Histopathological examination showing characteristic glomerular lesions 13
Urinalysis indicating proteinuria and/or hematuria 13
Renal biopsy for definitive diagnosis and classification (e.g., FSGS, collapsing glomerulopathy) 2
Imaging studies (e.g., ultrasound, MRI) to assess kidney structure and function 1Management
First-line treatments: Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to reduce proteinuria and slow disease progression 13
Adjunctive therapies: Corticosteroids for steroid-responsive cases of FSGS 2
Monitoring: Regular assessment of renal function and proteinuria levels 13Special Populations
Pregnancy: Limited data; close monitoring of renal function and proteinuria essential 13
Pediatrics: Early diagnosis and management crucial; FSGS can have variable outcomes 2
Elderly: Consider comorbidities and renal reserve when selecting treatments 13
Comorbidities: Tailor management considering coexisting conditions like hypertension or malignancy 2Key Recommendations
Utilize ACE inhibitors or ARBs for proteinuria reduction and to slow glomerulosclerosis progression (Evidence: Strong 13)
Consider renal biopsy for definitive diagnosis and classification of glomerulosclerosis subtypes (Evidence: Moderate 2)
Monitor renal function and proteinuria closely in all patients to guide treatment adjustments (Evidence: Moderate 13)References
1 Fogo AB. Gains in understanding of podocyte loss. Kidney international 2021. link
2 Loi S, Perry GJ, Standish H, Dowling J. Glomerulosclerosis: a paraneoplastic phenomenon?. Nephrology (Carlton, Vic.) 2004. link
3 Wardle EN. Cellular biology of glomerulosclerosis. Renal failure 1994. link